DRE suffers from a high false positive rate (10), while PSA is a non-specific blood biomarker that can be elevated even in the absence of PCa (11), and even low levels do not preclude the presence of high- or medium-grade PCa (12). The gene discussed is KLK3; the disease is posterior cortical atrophy.